Wyniki wyszukiwania dla: HYPOKSJA

• Anticancer imidazoacridinone C-1311 inhibits hypoxia-inducible factor-1α (HIF-1α), vascular endothelial growth factor (VEGF) and angiogenesis

  Publikacja

  • J. Paradziej-Łukowicz
  • A. Skwarska
  • G. Peszyńska-Sularz
  • A. Brillowska-Dąbrowska
  • J. Konopa

  - CANCER BIOLOGY & THERAPY - Rok 2011

  Antitumor imidazoacridinone C-1311 is a DNA-reactive topoisomerase II and FLT3 receptor tyrosine kinase inhibitor. Here, we demonstrate the mechanism of C-1311 inhibitory action on novel targets: hypoxia-inducible factor-1α (HIF-1α), vascular-endothelial growth factor (VEGF), and angiogenesis. In a cell-free system, C-1311 prevented HIF-1α binding to an oligonucleotide encompassing a canonical hypoxia-responsive element (HRE),...

  Pełny tekst do pobrania w portalu